HearingAssist Control vs Lexie B3
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

HearingAssist Control
The HearingAssist Control is a mid-priced OTC behind-the-ear hearing aid available at $549. In our lab testing, it earned a B grade with a SoundScore of 3.3/5, placing it in the top 77% of OTC hearing aids tested. This device demonstrates solid speech performance, scoring above the category average in both quiet and noisy environments. Speech in quiet earned a solid 3.4/5, while speech in noise scored 2.0/5—above average for the category but only mixed in absolute terms. Feedback handling is excellent at 5.0/5, meaning wearers should experience minimal whistling during normal use. The HearingAssist Control has notable limitations. Music streaming scored 0.0/5, indicating this device does not support audio streaming functionality—a significant gap compared to many competitors in this price range. Own-voice comfort scored 2.1/5, which is below the category average and may result in a hollow or boomy perception of your own voice. For shoppers considering this price tier, alternatives like the Yeasound RIC800 (4.73/5) and Sony CRE-E10 (4.66/5) offer substantially higher overall sound performance. The HearingAssist Control may suit buyers prioritizing speech clarity and feedback stability who don't need streaming capabilities, but most users would benefit from exploring higher-scoring options at similar price points.
Choice

Lexie B3
The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit